Showing results (371-380 of 394) with videos related to

Sort By:
Pageof 40
Arteriosclerosis, Thrombosis, and Vascular Biology|November 22, 2008
G-protein-coupled receptors as signaling targets for antiplatelet therapySusan S Smyth, Donna S Woulfe, Jeffrey I Weitz, et al.
Journal of Medicinal Chemistry|April 2, 2004
Discovery of novel 2,8-diazaspiro[4.5]decanes as orally active glycoprotein IIb-IIIa antagonistsMukund M Mehrotra, Julie A Heath, Mark S Smyth, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2010
Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulationHarald M H G Albers, Anping Dong, Laurens A van Meeteren, et al.
The Journal of Infectious Diseases|August 4, 2012
Nasal carriage as a source of agr-defective Staphylococcus aureus bacteremiaDavida S Smyth, Jared M Kafer, Gregory A Wasserman, et al.
European Journal of Neurology|June 12, 2012
Neurosarcoidosis-related intracranial haemorrhage: three new cases and a systematic review of the literatureJ P O'Dwyer, B A Al-Moyeed, M A Farrell, et al.
The Journal of Biological Chemistry|January 14, 2009
Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosisZehra Pamuklar, Lorenzo Federico, Shuying Liu, et al.
Journal of Clinical and Translational Science|April 18, 2022
KL2 scholars' perceptions of factors contributing to sustained translational science career successSusan S Smyth, Barry S Coller, Rebecca D Jackson, et al.
Frontiers in Microbiology|December 28, 2020
Loop-Mediated Isothermal Amplification (LAMP) as a Rapid, Affordable and Effective Tool to Involve Students in Undergraduate ResearchAndrew V Nguyen, Amos Orlofsky, Kaylynn Pubill, et al.
Stem Cells Translational Medicine|September 16, 2015
Pharmacological Elevation of Circulating Bioactive Phosphosphingolipids Enhances Myocardial Recovery After Acute InfarctionYuri M Klyachkin, Prabakara R Nagareddy, Shaojing Ye, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2005
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS TrialJ H Alexander, H Yang, R C Becker, et al.
Pageof 40